Serum Metabolomics Study of Traditional Chinese Medicine Formula （Shen Qi Tiao Ti Formula） Intervention to Polycystic Ovary Syndrome
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03623451|
Recruitment Status : Unknown
Verified February 2020 by Yan Li, Heilongjiang University of Chinese Medicine.
Recruitment status was: Active, not recruiting
First Posted : August 9, 2018
Last Update Posted : February 18, 2020
|Condition or disease||Intervention/treatment||Phase|
|Polycystic Ovary Syndrome||Drug: Chinese Medicine Formula||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||105 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Serum Metabolomics Study of Traditional Chinese Medicine Formula （Shen Qi Tiao Ti Formula） Intervention to Polycystic Ovary Syndrome|
|Actual Study Start Date :||August 10, 2018|
|Actual Primary Completion Date :||August 31, 2019|
|Estimated Study Completion Date :||June 30, 2020|
Experimental: Chinese Medicine Formula
All 100 patients were treated with Chinese Medicine Formula(CMF) for three menstrual cycles.
Drug: Chinese Medicine Formula
Chinese Medicine Formula, composed of American ginseng 10g, Poria cocos 15g, bighead atractylodes rhizome 20g, Astragalus mongholicus 30g, Crataegus pinnatifida Bunge 20g, Salvia miltiorrhiza Bge. 20g, Pericarpium Citri Reticulatae 10g will be decocted and packaged into vacuum packs by the pharmaceutical department of First Affiliated Hospital, Heilongjiang University of Chinese Medicine (140 mL/pack). Subjects will take 2 packages per day for three months.
- The fatty acid amides (FAAs) metabolite changes [ Time Frame: 3 months ]The metabolic changes before and after treatment
- The sulfated steroids metabolite changes [ Time Frame: 3 months ]The metabolic changes before and after treatment
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03623451
|First Affiliated Hospital, Heilongjiang University of Chinese Medicine|
|Harbin, Heilongjiang, China, 150040|